STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
62
13F, latest reported quarter
What the filings say about CNTN
Insiders, 180 days
-$258.2K net sold
1 seller · 0% of sales under a 10b5-1 plan
Canton Strategic insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Canton Strategic Holdings, Inc. insiders sold a net $258.2K of stock across 6 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 4.5% of the 224,526 shares held after it.
No other insider sold within 30 days.
62 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Stetz Gary S. sold about $34.5K of CNTN on May 22, 2026, the largest insider sale at the company on our record; 62 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 7.5% of the 199,526 shares held after it.
No other insider sold within 30 days.
62 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Stetz Gary S. sold about $51.0K of CNTN on May 22, 2026, the largest insider sale at the company on our record; 62 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 8.8% of the 169,526 shares held after it.
No other insider sold within 30 days.
62 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Stetz Gary S. sold about $51.1K of CNTN on May 22, 2026, the largest insider sale at the company on our record; 62 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 6.3% of the 159,526 shares held after it.
No other insider sold within 30 days.
62 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Stetz Gary S. sold about $34.0K of CNTN on May 22, 2026, the largest insider sale at the company on our record; 62 funds added in the latest 13F quarter.
6 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CNTN planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CNTN mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Onchain Economy ETF
$128.9K position · as of 2026-06-30
0.2%
ARK Blockchain & Fintech Innovation ETF
$752.8K position · as of 2026-07-31
0.1%
NVIT GS Small Cap Equity Insights Fund
$76.9K position · as of 2026-06-30
0.0%
Goldman Sachs Variable Insurance Trust Small Cap Equity Insights Fund
$73.8K position · as of 2026-06-30
0.0%
iShares Micro-Cap ETF
$418.5K position · as of 2026-06-30
0.0%
1290 VT Micro Cap Portfolio
$28.2K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $258.2K sold by insiders over 180 days, 62 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM CNTN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$1.5M
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM CNTN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
-1,287%
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM CNTN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term debt only, 2022-12-31 (42 months older than the period end); equity 2026-06-30
Debt to equity CNTN
FY Dec 2025
0.00x
FY Dec 2024
0.59x
FY Dec 2023
0.08x
FY Dec 2022
0.14x
FY Dec 2021
n/a
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.13x
Jun 2025
2.10x
Mar 2025
n/a
Dec 2024
0.59x
Sep 2024
0.26x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-28.68x
TTM operating cash flow over long-term debt only, 2022-12-31 (42 months older than the period end)
Cash flow to debt CNTN
FY Dec 2025
-20.87x
FY Dec 2024
-14.11x
FY Dec 2023
-9.45x
FY Dec 2022
-8.48x
FY Dec 2021
-1.41x
Jun 2026
-28.68x
Mar 2026
-27.27x
Dec 2025
-20.87x
Sep 2025
-11.28x
Jun 2025
-12.59x
Mar 2025
-13.93x
Dec 2024
-14.11x
Sep 2024
-12.01x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-43.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CNTN
FY Dec 2025
-18.0%
FY Dec 2024
-233.7%
FY Dec 2023
-127.0%
FY Dec 2022
-1,973%
FY Dec 2021
n/a
Jun 2026
-43.1%
Mar 2026
-34.4%
Dec 2025
-18.0%
Sep 2025
-225.0%
Jun 2025
-340.3%
Mar 2025
-400.4%
Dec 2024
-233.7%
Sep 2024
-454.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-34.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CNTN
FY Dec 2025
-13.7%
FY Dec 2024
-166.3%
FY Dec 2023
-105.7%
FY Dec 2022
-231.8%
FY Dec 2021
-481.6%
Jun 2026
-34.6%
Mar 2026
-27.5%
Dec 2025
-13.7%
Sep 2025
-159.4%
Jun 2025
-222.7%
Mar 2025
-236.7%
Dec 2024
-166.3%
Sep 2024
-257.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on invested capital CNTN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed CNTN
FY Dec 2025
n/a
FY Dec 2024
-238.2%
FY Dec 2023
-128.9%
FY Dec 2022
-843.6%
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
-216.2%
Jun 2025
-331.1%
Mar 2025
-405.3%
Dec 2024
-238.2%
Sep 2024
-465.7%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing CNTN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
0.04x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$108.6M
market value at close 2026-10-26 on 2026-08-13 shares, plus long-term debt only, 2022-12-31 (42 months older than the period end), minus cash 2026-06-30
Enterprise value CNTN
FY Dec 2025
$95.0M
FY Dec 2024
$230.2K
FY Dec 2023
$123.5M
FY Dec 2022
$1.7B
FY Dec 2021
n/a
Jun 2026
$160.4M
Mar 2026
$174.0M
Dec 2025
$95.0M
Sep 2025
$6.3M
Jun 2025
$3.7M
Mar 2025
$81.4K
Dec 2024
$230.2K
Sep 2024
-$1.2M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield CNTN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing CNTN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CNTN ranks highest on institutional and government (49th percentile) and financial health (46th), and lowest on risk and compliance (15th), among Financial Services peers.
Profitability
28
Inputs
Return on equity-43.1% · 27 pct, sector of 205
Return on assets-34.6% · 28 pct, sector of 266
Return on invested capitalthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employedthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Financial health
46
Inputs
Debt to equity0.00x · 87 pct, sector of 181
Cash flow to debt-28.68x · 5 pct, sector of 141
Insider conviction
30
Inputs
Net Form 4 buying (codes P and S), 180d-$258K · 61 pct, sector of 161
Insider buyers, 180d0 · 0 pct, sector of 165
Institutional and government
49
Inputs
Funds adding, latest quarter62 · 49 pct, sector of 278
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
15
Inputs
Short interest, % of float+11.3% · 17 pct, sector of 390
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+58.4% · 13 pct, sector of 175
2 not measured: Growth, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CNTN filings, in plain words
Are Canton Strategic insiders buying or selling CNTN?
In the 180 days to 2026-10-28, Canton Strategic insiders were net sellers, a net $258.2K across purchases and sales reported on Form 4, by 1 seller.
Read the full summary
In the 180 days to 2026-10-28, Canton Strategic insiders were net sellers of CNTN, a net $258.2K across purchases and sales reported on Form 4 by 1 seller. None of the 6 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.